Constipation and Irritable Bowel Syndrome Flashcards
Functions of the large intestine?
- mixing and dehydration of fecal material
- storage until evacuation is convenient
- salvaging of water, salt and some nutrients (fat soluable vitamins like vitamin K)
Diagnosing Constipation?
Must include 2 or more of the following:
- straining during at least 25% of defecations
- lumpy or hard stools in at least 25% of defecations
- sensation of incomplete evacuation for at least 25% of defecations
- sensations of anorectal obstruction/ blockage for more than 25% of defecations
- manual manvers to facilitate at least 25% of defecations
- fewer than three
functional bowel disorder characterized by symptoms of abdominal pain or discomfort and associated with disturbed defecation
Irritable bowel syndrome
Associated Conditions with IBS
- fibromyalgia
- chronic fatigue syndrome (also known as systemic exertion intolerance disease)
- gastroesophageal reflux disease
- functional dyspepsia
- non-cardiac chest pain
- psychiatric disorders including major depression, anxiety, and somatization
Diagnosis of IBS?
recurrent abdominal pain or discomfort on average 1 day/week in the last 3 months associated with two or more of the following
- related to defecation
- associated with a change in frequency of stool
- assoicated with a change in form (appearance) of stool
what are the four subtypes of IBS?
- diarrhea predominant (IBS-D)
- constipation-predominant IBS
- mixed symtpom IBS
- IBS unclassified (meet criteria for IBS but not specifically a subtype
pts change subtypes, often starting in D & C and moving to M
medications that can cause constipation?
narcotics, calcium channel blockers, antidepressants, antipsychotics, diuretics, anticonvulsants
red flag symptoms for constipation
- fever
- weight loss
- blood in stools- particularly turning the toilet water red
- anemia
- family history of IBD or colon cancer
- abnormal physical findings
- abnormal blood work
- waking from sleep due to pain or needing to stool
categories of constipation
severe idopathic chronic constipation
- Normal transit
- slow transit or colonic inertia
- outlet delay - transit throught the colon is normal but slows at the rectum
Dyssynergic defecation
megacolon
- failure of relaxation or inappropriate contraction resulting in a narrowing of the anorectal angle and an increase in the pressures of the anal canal
- this can be conscious or an unconscious act
dyssynergic defecation
- MOA: primarily works by absorbing water and increasing fecal mass which can lead to increase frequency and softer stools
- can be used alone or with other therapies
- side effect: gas and bloating
- contraindicated: if concerned for bowel obstruction
- Psyllium, Methylcellulose
Bulk forming laxatives
- MOA: Primarily works by lowering the surface tension of stool so water can more easily enter the stool. thus stools are softer and easier for normal colon transit to move
- often used in combination with bulk forming laxative
- se: contact dermatitis have been reported, diarrhea and abdominal cramping
- contraindicated: if concerned for bowel obsruction, acute abdomen, appendicitis
- Docusate sodium
Surfactants (stool softners)
- MOA: These medication increase water secretion which in turn increase stool frequency
- miralax, lactulose, Mg citrate
- caution, watch out for electrolyte and fluid disturbances in patients with renal and cardiac dysfunction. use caustion in elderly pts
- SE: nausea, bloating, gas, diarrhea, rectal irritation, watery stools
- polyethylene glycol, magnesium citrate, glycerin
Osmotic Agents
- MOA: alters electrolyte transport through the intestinal mucosa which increases intestinal motility
- abuse of these medications can cause hypokalemia, protein losing enteropathy and salt overload
- no evidence that chronic use causes structural or functional impairment of the colon so long term use is fine
- SE: gastric or rectal irritation, melanosis coli (dark pigmentation), cramping, N/V
- contraindicated: acute abdomen, GI obstruction, or perforation, toxic megacolon
- bisacodyl 5mg, senna 8.6mg
stimulant laxatives
- minimally absorbed peptide agnoist of the guanylate cylcase C-receptor
- MOA: stimulates intestinal fluid secretion and transit
- SE: diarrhea, abdominal pain and bloating
- contraindicated: pts less than 18, concern for obstruction
Linzess
- MOA: increases intestinal fluid secretion and motility
- best reserved for patients with severe constipation in whom other approaches have been successful
- SE: nausea, diarrhea, headaceh
- caution/contraindicated: severe diarrhea, liver impairment, concern for obstruction
Chloride channel activator- Lubiprostone
three general mechanisms of IBS
- Hypersensitivity- enhanced visceral perception and pain
- altered gut activity- motility and secretion are altered in IBS patients with triggers to alert the activities including eating, gut distention, inflammation, bacterial, psychosocial stress and other environemental stimuli
- dysregulation- of the brain-gut axis- suspected altered perception by the brain and the signals from the gut are possibly distorted
risk factors for development of post infectious IBS
- female gender, younger age
- smoking
- prolonged fever
- severe diarrheal illness
- weight loss > 10lbs during diarrheal illness
- bloody diarrhea
- pre-existing anxiety or depression, history of stress
- treated with antibiotics
- sleep disturbance
- Psychosocial factors of IBS
- there is a striking prevalence of psychiatric comobidity among IBS patients
- key life events that can influence IBS include abuse (emotional, sexual, or physical) stressful life events
- 80% of IBS pts also have- depression, somatization disorder, generalized anxiety, panic disorder, phobias
- can reduce pain and bloating
- best if used intermittently
- MOA: act via anticholinergic or antimuscurinic properties causing selective inhibition of gastrointestinal smooth muscle which reduces intestinal motility and spasm
- se: xerostomia, dry eye, UA retention, constipation, sleepiness
- caution: elderly, CHF, CAD, renal/hepatic impairment, risk of obstruction, patient with glaucoma
- dicylomine, hyoscyamine
Antispasmodic agents
- MOA: suspected effect on the enteric nervous system
- more effective than placebo at relieving global IBS symptoms
- SE: drowsiness, xerostomia, dizziness, constipation, blurred vision, palpation
- caution: withdrawal if stopped suddenly, elderly, GI/GU obstruction, urinary retention, glaucoma, pregnancy
- amitriptyline, nortriptyline
antidepressants
- MOA: slow stool transit time and frequency by binding gut wall opioid receptors and inhibiting peristalsis
- no effect on abdominal discomfort or pain
- SE: constipation, nausea, abdominal crampin, dizziness, drowsiness
- contraindicated: abdominal pain w/out diarrhea, bloody diarrhea, UC less than 2 yrs old, pseudomembranous colitis
Loperamide and lomotil
- MOA: antibiotic
- SE: nausea, elevated ALT
- caution/contraindicated- if pt has C.diff, child-pugh, possible fetal harm
rifaxamin (for IBS-D)
Lifestyle contributions
- Smoking
- volume and timing of meals- do they have a job that hours keep changing, do they eat one large meal a day vs. small one
- menses: consider birth control to reduce the frequency of periods
- aerophagia- increase gas issues